Back to User profile » Dr Ling Xu

Papers published by Dr Ling Xu:

Corrigendum

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

OncoTargets and Therapy 2021, 14:2337-2338

Published Date: 6 April 2021

Corrigendum

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

OncoTargets and Therapy 2021, 14:253-254

Published Date: 12 January 2021

Original Research

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling

Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

OncoTargets and Therapy 2020, 13:10983-10994

Published Date: 28 October 2020